Log in to save to my catalogue

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment...

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9243911

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

About this item

Full title

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Publisher

Cham: Springer International Publishing

Journal title

CNS drugs, 2022-07, Vol.36 (7), p.659-679

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Treatment-resistant schizophrenia (TRS) will affect about one in three patients with schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be treated as soon as possible to improve their chances of achieving remission. Despite its effectiveness, concern over side effects, monitoring requirements, and inexperience with...

Alternative Titles

Full title

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9243911

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9243911

Other Identifiers

ISSN

1172-7047

E-ISSN

1179-1934

DOI

10.1007/s40263-022-00932-2

How to access this item